BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 31733339)

  • 1. Role of sphingolipids in the pathogenesis of intrahepatic cholestasis.
    Mikucka-Niczyporuk A; Pierzynski P; Lemancewicz A; Kosinski P; Charkiewicz K; Knas M; Kacerovsky M; Blachnio-Zabielska A; Laudanski P
    Prostaglandins Other Lipid Mediat; 2020 Apr; 147():106399. PubMed ID: 31733339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal cardiac dysfunction in intrahepatic cholestasis of pregnancy is associated with elevated serum bile acid concentrations.
    Vasavan T; Deepak S; Jayawardane IA; Lucchini M; Martin C; Geenes V; Yang J; Lövgren-Sandblom A; Seed PT; Chambers J; Stone S; Kurlak L; Dixon PH; Marschall HU; Gorelik J; Chappell L; Loughna P; Thornton J; Pipkin FB; Hayes-Gill B; Fifer WP; Williamson C
    J Hepatol; 2021 May; 74(5):1087-1096. PubMed ID: 33276032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymatic quantification of total serum bile acids as a monitoring strategy for women with intrahepatic cholestasis of pregnancy receiving ursodeoxycholic acid treatment: a cohort study.
    Manna LB; Ovadia C; Lövgren-Sandblom A; Chambers J; Begum S; Seed P; Walker I; Chappell LC; Marschall HU; Williamson C
    BJOG; 2019 Dec; 126(13):1633-1640. PubMed ID: 31483939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study).
    Kong X; Kong Y; Zhang F; Wang T; Yan J
    Medicine (Baltimore); 2016 Oct; 95(40):e4949. PubMed ID: 27749550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ursodeoxycholic acid versus placebo in the treatment of women with intrahepatic cholestasis of pregnancy (ICP) to improve perinatal outcomes: protocol for a randomised controlled trial (PITCHES).
    Chappell LC; Chambers J; Dixon PH; Dorling J; Hunter R; Bell JL; Bowler U; Hardy P; Juszczak E; Linsell L; Rounding C; Smith A; Williamson C; Thornton JG
    Trials; 2018 Nov; 19(1):657. PubMed ID: 30482254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrahepatic cholestasis of pregnancy: observational study of the treatment with low-dose ursodeoxycholic acid.
    Joutsiniemi T; Timonen S; Linden M; Suvitie P; Ekblad U
    BMC Gastroenterol; 2015 Jul; 15():92. PubMed ID: 26215400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrahepatic cholestasis of pregnancy: changes in maternal-fetal bile acid balance and improvement by ursodeoxycholic acid.
    Brites D
    Ann Hepatol; 2002; 1(1):20-8. PubMed ID: 15114292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy course in patients with intrahepatic cholestasis of pregnancy treated with very low doses of ursodeoxycholic acid.
    Grymowicz M; Czajkowski K; Smolarczyk R
    Scand J Gastroenterol; 2016 Jan; 51(1):78-85. PubMed ID: 26152830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S-adenosylmethionine versus ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy: preliminary results of a controlled trial.
    Floreani A; Paternoster D; Melis A; Grella PV
    Eur J Obstet Gynecol Reprod Biol; 1996 Aug; 67(2):109-13. PubMed ID: 8841797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased syndecan-1 and glypican-3 predict poor perinatal outcome and treatment resistance in intrahepatic cholestasis.
    Gümüş Güler B; Özler S
    Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):271-276. PubMed ID: 31919038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotropin-releasing hormone expression in patients with intrahepatic cholestasis of pregnancy after ursodeoxycholic acid treatment: an initial experience.
    Zhou F; Zhang L; He MM; Liu ZF; Gao BX; Wang XD
    Curr Med Res Opin; 2014 Aug; 30(8):1529-35. PubMed ID: 24665980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of serum bile acid level analysis and treatment with ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a case series from central Europe.
    Ambros-Rudolph CM; Glatz M; Trauner M; Kerl H; Müllegger RR
    Arch Dermatol; 2007 Jun; 143(6):757-62. PubMed ID: 17576942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy.
    Brites D; Rodrigues CM; Oliveira N; Cardoso M; Graça LM
    J Hepatol; 1998 Jan; 28(1):91-8. PubMed ID: 9537870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy: a randomized controlled trial.
    Joutsiniemi T; Timonen S; Leino R; Palo P; Ekblad U
    Arch Gynecol Obstet; 2014 Mar; 289(3):541-7. PubMed ID: 23978872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bile acid patterns in meconium are influenced by cholestasis of pregnancy and not altered by ursodeoxycholic acid treatment.
    Rodrigues CM; Marín JJ; Brites D
    Gut; 1999 Sep; 45(3):446-52. PubMed ID: 10446117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The reversed feto-maternal bile acid gradient in intrahepatic cholestasis of pregnancy is corrected by ursodeoxycholic acid.
    Geenes V; Lövgren-Sandblom A; Benthin L; Lawrance D; Chambers J; Gurung V; Thornton J; Chappell L; Khan E; Dixon P; Marschall HU; Williamson C
    PLoS One; 2014; 9(1):e83828. PubMed ID: 24421907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progesterone metabolites and bile acids in serum of patients with intrahepatic cholestasis of pregnancy: effect of ursodeoxycholic acid therapy.
    Meng LJ; Reyes H; Axelson M; Palma J; Hernandez I; Ribalta J; Sjövall J
    Hepatology; 1997 Dec; 26(6):1573-9. PubMed ID: 9398000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Insights on Intrahepatic Cholestasis of Pregnancy.
    Floreani A; Gervasi MT
    Clin Liver Dis; 2016 Feb; 20(1):177-89. PubMed ID: 26593298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid.
    Glantz A; Marschall HU; Lammert F; Mattsson LA
    Hepatology; 2005 Dec; 42(6):1399-405. PubMed ID: 16317669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal PR Interval in Pregnancies with Intrahepatic Cholestasis of Pregnancy: A Case-Control Study.
    Guerra M; Montaño I; Haye MT; Toro V; Maiz N
    Am J Perinatol; 2024 May; 41(S 01):e2964-e2969. PubMed ID: 37774745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.